Russell Investments Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932K | Buy |
143,453
+127,113
| +778% | +$826K | ﹤0.01% | 2094 |
|
|
2025
Q1 | $130K | Buy |
16,340
+16,335
| +326,700% | +$130K | ﹤0.01% | 2700 |
|
|
2024
Q4 | $63 | Sell |
5
-26
| -84% | -$328 | ﹤0.01% | 3682 |
|
|
2024
Q3 | $432 | Sell |
31
-1,720
| -98% | -$24K | ﹤0.01% | 3584 |
|
|
2024
Q2 | $24.1K | Buy |
+1,751
| New | +$24.1K | ﹤0.01% | 2907 |
|
|
2023
Q3 | – | Sell |
-3,530
| Closed | -$42.1K | – | 3550 |
|
|
2023
Q2 | $42.1K | Sell |
3,530
-1,600
| -31% | -$19.1K | ﹤0.01% | 2747 |
|
|
2023
Q1 | $68.6K | Buy |
+5,130
| New | +$68.6K | ﹤0.01% | 2661 |
|